In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

ESC 365

my activity my activity esc
 
Back
GARFIELD-AF prospective registry - Adverse one-year outcomes for patients newly treated with oral anticoagulants plus antiplatelet therapy after a diagnosis of atrial fibrillation
2018

Congress : ESC Congress

  • Topic : arrhythmias and device therapy
  • Sub-topic : Atrial Fibrillation - Stroke Prevention
  • Session type : Late-Breaking Science
  • FP Number : 5878
15 views
15 views

Please login to My ESC

This content may be restricted, please sign in to check your access.

Other presentations from this session

Late Breaking Registry Results 2

  • ESC Congress 2018
  • Other
  • Late-Breaking Science
  • 28 August 2018
  • 14:30 - 15:45
session 2018 2018
12

Other presentations from this speaker

no speaker photo speaker

Keith Fox

Senior Researcher, University of Edinburgh,Edinburgh (United Kingdom)

28

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are